Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Iowa for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Iowa only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Iowa (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Lindsay Orris (NPI 1225263833)

Field	Value
Entity Type	Individual
Organization	Lindsay Orris
Address	2979 Victoria St
City	Bettendorf
State	IA
ZIP	52722
Taxonomy	Internal Medicine Physician
NPI Enumerated	May 27, 2009

Payer Source	Total Paid
Medicare	$797.5K
Medicaid	$0

Key Findings

LINDSAY ORRIS is effectively a Medicare-focused practitioner with Total Medicare revenue of $797.5K and no Medicaid billing on file; this makes the provider effectively single-payer in the available public data and suggests their billed patient mix or contracting footprint does not include Medicaid. The provider’s NPI was enumerated on 2009-05-27 (~17 years ago), indicating a long tenure in practice which supports stable referral and treatment patterns over time.

Revenue concentration is high: the precomputed top 3 Medicare codes by revenue account for 49.7% of this provider's total Medicare revenue, indicating nearly half of Medicare income comes from a small set of injectable biologic drug administrations and related services. That concentration implies the practice’s business and cash flow are materially tied to a handful of high-cost infusion or injection products rather than predominantly office visits.

The single largest Medicare revenue driver is J9312 (rituximab) with $150.4K revenue (18.8% of Medicare revenue) and 2.4K claims; this code ranks #217 of 317 providers nationally (31st percentile), so the provider participates at a typical, unremarkable national volume for rituximab rather than as a national leader. Alongside J9312, J1602 (golimumab) ($143.1K; 17.9% share) and J0717 (certolizumab pegol) ($104K; 13.0% share) complete the top three and together form the clinical core driving near-term revenue.

The detailed code mix — dominated by high-revenue injectable biologic drug codes such as J9312, J1602, J0717, J0129, and J1745 — suggests the practice operates infusion or injection services frequently administered under direct physician supervision rather than relying primarily on procedural or surgery-based revenue. Office evaluation and management codes (99214, 99213) are present but account for a much smaller share of revenue, reinforcing that drug administration is the primary service line.

Competitive standing by national rank shows modest participation across most top drug codes: for example J1602 ranks at the 49th percentile nationally and J0717 at the 20th percentile, while several other biologic codes sit in mid-to-low percentiles; overall this pattern indicates a steady, typical-volume infusion practice rather than a major regional or national center of excellence for these agents. One specific code, J3262 (tocilizumab), is ranked at the 1st percentile nationally despite contributing $37K (4.6%); this label reflects very low comparative rank and should be interpreted as unusually low national volume for that particular code.

Clinical services beyond infusions are present but limited in revenue impact: E/M visits (99214, 99213) together make up only a small fraction of the Medicare revenue ($35.4K and $10.9K respectively), and chemotherapy administration codes (96413, 96415) and infusion encounter codes (96365, 96372) appear at modest volumes. This mix points toward a practice model centered on chronic biologic therapy administration with routine office care supporting those services.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

45 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9312	Injection, rituximab, 10 mg	2,350	$60	$150.4K
J1602	Injection, golimumab, 1 mg, for intravenous use	13,010	$10	$143.1K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	26,000	$1	$104K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	2,530	$30	$85.8K
J3111	Injection, romosozumab-aqqg, 1 mg	9,870	$10	$79K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	2,320	$30	$60.3K
J0897	Injection, denosumab, 1 mg	2,400	$20	$43.2K
J3262	Injection, tocilizumab, 1 mg	7,400	$10	$37K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	430	$80	$35.4K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	110	$120	$13.2K

Showing 1–10 of 45

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 45 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Iowa Distribution

Lindsay Orris — 1 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Iowa

Full comparison — all codes billed, vs. state median

45 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3262	9	10	35,440	$1	$233.1K
J0129	15	20	5,950	$30	$218.3K
J9312	4	10	3,190	$60	$198.4K
J1602	7	10	13,010	$10	$153.6K
J3111	12	20	12,180	$10	$112K
J0717	6	20	23,500	$1	$93.9K
J1745	15	20	3,460	$30	$92.3K
J0897	71	190	1,920	$20	$74.1K
96413	47	80	210	$90	$24K
90694	468	570	90	$80	$14.7K

Showing 1–10 of 45

Related Providers

Other providers that share a Tax Identification Number (TIN) with Lindsay Orris, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Robert Behrens	IA	Medical Oncology Physician	$5.2M	$0
Audubon County Memorial Hospital	IA	Rural Health Clinic/Center	$0	$1.1M
Sunita Penmatcha	IA	Rheumatology Physician	$669.5K	$0
Mudappa Kalaiah	IA	Rheumatology Physician	$652.3K	$0
David Staub	IA	Rheumatology Physician	$484K	$0
Kyle Ulveling	IA	Cardiovascular Disease Physician	$325.1K	$0
Shelby Mescher	IA	Nurse Practitioner	$125.2K	$0
Caliste Hsu	IA	Surgery of the Hand (Surgery) Physician	$82.4K	$0
Richard Goding	IA	Orthopaedic Surgery Physician	$78.5K	$0
Kelsey Barger	IA	Physician Assistant	$34K	$0

Nearby Providers

Other providers in the same ZIP code as Lindsay Orris, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
New Choices Inc	IA	Developmentally Disabled Services Day Training Agency	$0	$72.6M
Bettendorf Community School District	IA	Local Education Agency (LEA)	$0	$7.4M
New Choices	IA	Community/Behavioral Health Agency	$0	$6.9M
Trinity Medical Center	IA	General Acute Care Hospital	$0	$5.2M
Helping Hands Transporting Services,llc	IA	Non-emergency Medical Transport (VAN)	$0	$3.5M
Richard Yemm	IA	Ophthalmology Physician	$2.4M	$6.1K
Gengastro LLC	IA	Ambulatory Surgical Clinic/Center	$1.1M	$1M
Martin O'malley	IA	Ophthalmology Physician	$1.9M	$2.7K
New Choices LLC	IA	Home Health Agency	$0	$1.9M
Genesis Health System	IA	Home Health Agency	$0	$1.8M

Lindsay Orris — Billing Profile & Reimbursement Data

Sign up for Lindsay Orris — Billing Profile & Reimbursement Data policy alerts

Lindsay Orris — Billing Profile & Reimbursement Data

Sign up for Lindsay Orris — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References